The American Association for Cancer Research delivered a letter to Rep. Kevin Brady (R-TX), conference chair of the House-Senate Conference Committee for the Tax Cuts and Jobs Act [HR 1], urging the committee to remove two provisions from the tax reform bill that, if enacted, would negatively impact cancer researchers and patients.
While doing somewhat-routine reporting on this year’s Senate Appropriations Committee bills, Paul Goldberg, editor and publisher of The Cancer Letter, quickly realized that he was seeing a full bipartisan rejection of President Donald J. Trump’s plan to defund and therefore dismantle biomedical research in the United States.
